Viewing Study NCT04381832


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 9:10 AM
Study NCT ID: NCT04381832
Status: COMPLETED
Last Update Posted: 2025-07-22
First Post: 2020-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
Sponsor: Arcus Biosciences, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ARC-6
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View